Epbriv 0.88mg Injection: Effective Treatment for Your Needs

Epbriv 0.88mg Injection

Description

• Epbriv 0.88mg Injection is a chemotherapy drug containing eribulin, an antineoplastic agent.
• It is used in adults for advanced breast cancer or liposarcoma when other treatments have failed.

Uses

• Advanced breast cancer
• Liposarcoma

Therapeutic Effects

• Stops the growth and spread of cancer cells by targeting microtubule growth and causing tubulin to clump together, disrupting cell division and triggering apoptosis.

Interaction with Other Drugs

• Inform your doctor about all medications, including prescription, over-the-counter, nutritional supplements, and herbal products, as interactions may reduce effectiveness or cause side effects.

Storage

• Store in the refrigerator between 2–8 °C.
• Keep in original packaging.
• Protect from light and moisture.
• Keep out of reach of children and pets.

Administration

• Administered by a healthcare provider via intravenous infusion.
• Dosage, duration, and frequency determined by healthcare provider based on age, body weight, and condition severity.
• Do not miss or delay doses without consulting a healthcare provider.
• Do not stop treatment without physician advice.

Safety Advice

• Pregnancy: unsafe; may cause fetal harm. Consult a doctor if pregnant or planning pregnancy.
• Breastfeeding: not recommended; unknown if it passes through breast milk.
• Lungs: can cause blood clots and inflammation. Inform doctor if you have lung disorders.
• Liver: can affect liver function. Inform doctor if you have pre-existing liver problems.
• Alcohol: avoid or limit alcohol intake as it can enhance liver damage risk.
• Driving: may cause tiredness and dizziness, impairing driving ability.

Side Effects

• Serious: sepsis, severe allergic reaction, Stevens-Johnson syndrome.
• Common: decrease in white or red blood cells, tiredness, nausea, vomiting, constipation, diarrhea, numbness, tingling, fever, loss of appetite, weight loss, difficulty breathing, cough, joint, muscle, and back pain, headache, hair loss.

Word of Advice

• Regular liver function and heart function monitoring via blood tests.
• Reliable birth control for women during treatment and for at least three months after stopping.
• Consult oncologist for dental treatment.
• Discuss fertility concerns with doctor before starting treatment.
• Maintain adequate fluid intake and dietary adjustments if experiencing diarrhea or constipation.

FAQs

1. What is the most important information I should know while taking Epbriv 0.88mg Injection? Epbriv 0.88mg Injection can cause serious adverse effects such as low white blood cell count, numbness, tingling, and pain in the hands and feet. Inform your physician immediately if you face any of these symptoms.

2. Does Epbriv 0.88mg Injection cause infertility? Yes, Epbriv 0.88mg Injection causes infertility in men and women. It is necessary to use effective birth control methods during the treatment and for three weeks (females) and 14 weeks (males) after the final dose of the injection.

3. Is hair loss caused by Epbriv 0.88mg Injection reversible? Hair loss is a common side effect of Epbriv 0.88mg Injection. It is reversible, but it depends totally on the severity of the hair loss and varies from person to person. Consult your doctor if you have severe hair loss.

4. Do I have to follow any special dietary requirements while taking Epbriv 0.88mg Injection? It depends upon the severity of the disease condition. You can have a normal diet until your physician tells you to follow any special food or diet chart. Check with your doctor if you have any nutrition concerns.

5. What should I do if I miss taking Epbriv 0.88mg Injection? It is important to get the injection at the right time. If you missed your appointment, contact your healthcare provider and schedule your dosing immediately. Keep follow-ups on your next schedule.

Fact Box

• Molecule name: Eribulin
• Therapeutic class: Anticancer
• Pharmacological class: Monoclonal antibody-drug conjugate
• Indications:
  • Advanced breast cancer
  • Liposarcoma
• Dosage form: Injections
• Habit forming: No

Tags: epbriv, injection, medical-drug, 0.88mg, pharmacy